Abbott Laboratories

NYSE:ABT  
125.79
+1.08 (+0.87%)
Products

Abbott Receives U.S. FDA Clearance For New Cardiac Mapping System To Improve How Doctors Treat Abnormal Heart Rhythms

Published: 01/12/2022 14:14 GMT
Abbott Laboratories (ABT) - Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms.
Abbott Laboratories - Received Clearance From U.S. Food and Drug Administration for Ensite X Ep System With Ensite Omnipolar Technology.